Pcas SA operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Pcas SA with three other
pharmaceutical manufacturers in Europe:
Laboratorio Reig Jofre SA
sales of 161.13 million Euro [US$195.55 million]
of which 87%
was Sale of Pharmaceutical Products),
(164.51 million Euro [US$199.64 million]
of which 84%
was EVT Execute), and
Vectura Group PLC
based in the United Kingdom
(£168.25 million [US$229.84 million]
of which 100%
was Pharmaceutical Prod).
During the year ended December of 2016, sales at
Pcas SA were 191.99 million Euro (US$233.00 million).
increase of 7.2%
versus 2015, when the company's sales were 179.09 million Euro.
This was the third consecutive year of growth at Pcas SA.
Sales of Pharmaceutical Synthesis saw an increase
7.6% in 2016, from
120.77 million Euro to 129.97 million Euro.